Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Benhamou

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Management of HCV-HIV patients]Stanislas Pol, Patrice Cacoub, Gilles Pialoux, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 24, 2024
Experience of People with Diabetes Treated with Insulin Delivery Systems in France: A Comparative Analysis of Multiple Daily Injections, Tubeless Pumps, Tubed Pumps, and Hybrid Closed LoopsJacques Beltrand, Pierre-Yves Benhamou, Carine Choleau, et al.
Diabetes Technology & Therapeutics|October 29, 2019
Characterization of Daily Glycemic Variability in Subjects with Type 1 Diabetes Using a Mixture of MetricsFei Zheng, Manon Jalbert, Florence Forbes, et al.
Diabetes Research and Clinical Practice|July 4, 2025
Glycemic variability and iatrogenic hypoglycemia: how to resolveLouis Monnier, Claude Colette, Eric Renard, et al.
Diabetes Care|January 12, 2021
Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-upCoralie Amadou, Sylvia Franc, Pierre-Yves Benhamou, et al.
Annals of Internal Medicine|June 19, 2002
Truth survival in clinical research: an evidence-based requiem?Thierry Poynard, Mona Munteanu, Vlad Ratziu, et al.
AIDS (London, England)|April 20, 2004
Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infectionNadia Alatrakchi, Vincent Di Martino, Vincent Thibault, et al.
Diabetes & Metabolism|November 24, 2024
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variabilityLouis Monnier, Claude Colette, Eric Renard, et al.
European Journal of Endocrinology|August 18, 2016
Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlagSandra Larcher, Anne-Sophie Gauchez, Sandrine Lablanche, et al.
Diabetes Care|May 30, 2013
Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetesAnne-Laure Borel, Jean-Louis Pépin, Laure Nasse, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Management of HCV-HIV patients]Stanislas Pol, Patrice Cacoub, Gilles Pialoux, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 24, 2024
Experience of People with Diabetes Treated with Insulin Delivery Systems in France: A Comparative Analysis of Multiple Daily Injections, Tubeless Pumps, Tubed Pumps, and Hybrid Closed LoopsJacques Beltrand, Pierre-Yves Benhamou, Carine Choleau, et al.
Diabetes Technology & Therapeutics|October 29, 2019
Characterization of Daily Glycemic Variability in Subjects with Type 1 Diabetes Using a Mixture of MetricsFei Zheng, Manon Jalbert, Florence Forbes, et al.
Diabetes Research and Clinical Practice|July 4, 2025
Glycemic variability and iatrogenic hypoglycemia: how to resolveLouis Monnier, Claude Colette, Eric Renard, et al.
Diabetes Care|January 12, 2021
Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-upCoralie Amadou, Sylvia Franc, Pierre-Yves Benhamou, et al.
Annals of Internal Medicine|June 19, 2002
Truth survival in clinical research: an evidence-based requiem?Thierry Poynard, Mona Munteanu, Vlad Ratziu, et al.
AIDS (London, England)|April 20, 2004
Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infectionNadia Alatrakchi, Vincent Di Martino, Vincent Thibault, et al.
Diabetes & Metabolism|November 24, 2024
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variabilityLouis Monnier, Claude Colette, Eric Renard, et al.
European Journal of Endocrinology|August 18, 2016
Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlagSandra Larcher, Anne-Sophie Gauchez, Sandrine Lablanche, et al.
Diabetes Care|May 30, 2013
Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetesAnne-Laure Borel, Jean-Louis Pépin, Laure Nasse, et al.
Pageof 17